Research & Clinical Trials
Latest Clinical Trial for Pleural Mesothelioma Opens in Georgia
- by Tim Povtak
- Research & Clinical Trials
- May 6, 2020
Dr. Nagla Abdel Karim of the Georgia Cancer Center has seen the effectiveness of cabozantinib with certain types of thyroid, kidney and liver cancers. She believes it may also work…
Read More
Mesothelioma Drug Combination Continues to Show Promise
- by Tim Povtak
- Research & Clinical Trials
- May 4, 2020
Pharmaceutical giant Bristol Myers Squibb continues to tout its immunotherapy combination of Opdivo and Yervoy for first-line treatment of patients with pleural mesothelioma cancer. Bristol Myers Squibb recently announced…
Read More
COVID-19 Pandemic Delays Mesothelioma Clinical Trials
- by Tim Povtak
- Research & Clinical Trials
- Apr 9, 2020
Medical centers across the country have slowed or stopped the enrollment of new patients in mesothelioma clinical trials because of the all-consuming COVID-19 pandemic. The pause in enrollment options…
Read More
Promising Data Supports Curcumin Treatment for Mesothelioma
- by Tim Povtak
- Research & Clinical Trials
- Mar 19, 2020
The plant-based substance curcumin could soon be included in the multidisciplinary treatment of malignant mesothelioma, according to a recent multicenter, international study review. Curcumin, an active compound found in the…
Read More
UPenn Research with Mesothelioma Blood Test Shows Promise
- by Tim Povtak
- Research & Clinical Trials
- Mar 16, 2020
Scientist Ian Blair at the University of Pennsylvania School of Medicine believes his team is close to identifying the variant of a blood-based biomarker that could diagnose asbestos disease in…
Read More
Mesothelioma Clinical Trial Testing New INBRX-109 Antibody
- by Sean Marchese
- Research & Clinical Trials
- Mar 12, 2020
A new clinical trial is testing an innovative approach to immunotherapy that could change the way antibodies target pleural mesothelioma tumors. Researchers at eight cancer centers…
Read More
Study to Clarify Radiation Benefits in Mesothelioma Patients
- by Tim Povtak
- Research & Clinical Trials
- Mar 3, 2020
An upcoming phase III clinical trial involving the National Cancer Institute should clarify the still-debatable benefits of using radiotherapy in combination with aggressive surgery for patients with pleural mesothelioma.
Read More
Mesothelioma Clinical Trial Involves Immunotherapy Before Surgery
- by Tim Povtak
- Research & Clinical Trials
- Feb 24, 2020
Three of the country’s leading cancer centers have opened a collaborative clinical trial that potentially could change surgical treatment of mesothelioma. Researchers will measure the safety and efficacy…
Read More
Mesothelioma Gene Therapy Trial Shows ‘Real Potential’
- by Tim Povtak
- Research & Clinical Trials
- Feb 17, 2020
Gene therapy is moving closer to becoming part of standard-of-care treatment for pleural mesothelioma, according to the latest multicenter clinical trial. The phase III trial, known as the…
Read More
Duke Completes Largest Study of Mesothelioma in Women
- by Tim Povtak
- Research & Clinical Trials
- Feb 5, 2020
Women diagnosed with peritoneal mesothelioma were 10 years younger on average than those with pleural mesothelioma in a recent case study at the Duke University Medical Center. It was the…
Read More
